These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19059777)

  • 1. Novel non-active site inhibitor of Cryptosporidium hominis TS-DHFR identified by a virtual screen.
    Martucci WE; Udier-Blagovic M; Atreya C; Babatunde O; Vargo MA; Jorgensen WL; Anderson KS
    Bioorg Med Chem Lett; 2009 Jan; 19(2):418-23. PubMed ID: 19059777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel allosteric covalent inhibitors of bifunctional Cryptosporidium hominis TS-DHFR from parasitic protozoa identified by virtual screening.
    Ruiz V; Czyzyk DJ; Valhondo M; Jorgensen WL; Anderson KS
    Bioorg Med Chem Lett; 2019 Jun; 29(11):1413-1418. PubMed ID: 30929953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the TS dimer interface in bifunctional Cryptosporidium hominis TS-DHFR from parasitic protozoa: Virtual screening identifies novel TS allosteric inhibitors.
    Ruiz VG; Czyzyk DJ; Kumar VP; Jorgensen WL; Anderson KS
    Bioorg Med Chem Lett; 2020 Aug; 30(16):127292. PubMed ID: 32631514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural studies provide clues for analog design of specific inhibitors of Cryptosporidium hominis thymidylate synthase-dihydrofolate reductase.
    Kumar VP; Cisneros JA; Frey KM; Castellanos-Gonzalez A; Wang Y; Gangjee A; White AC; Jorgensen WL; Anderson KS
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4158-61. PubMed ID: 25127103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two crystal structures of dihydrofolate reductase-thymidylate synthase from Cryptosporidium hominis reveal protein-ligand interactions including a structural basis for observed antifolate resistance.
    Anderson AC
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2005 Mar; 61(Pt 3):258-62. PubMed ID: 16511011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of the crossover helix impairs dihydrofolate reductase activity in the bifunctional enzyme TS-DHFR from Cryptosporidium hominis.
    Vargo MA; Martucci WE; Anderson KS
    Biochem J; 2009 Feb; 417(3):757-64. PubMed ID: 18851711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based approach to the development of potent and selective inhibitors of dihydrofolate reductase from cryptosporidium.
    Bolstad DB; Bolstad ES; Frey KM; Wright DL; Anderson AC
    J Med Chem; 2008 Nov; 51(21):6839-52. PubMed ID: 18834108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phylogenetic classification of protozoa based on the structure of the linker domain in the bifunctional enzyme, dihydrofolate reductase-thymidylate synthase.
    O'Neil RH; Lilien RH; Donald BR; Stroud RM; Anderson AC
    J Biol Chem; 2003 Dec; 278(52):52980-7. PubMed ID: 14555647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the structural basis of species selective, stereospecific inhibition for Cryptosporidium and human thymidylate synthase.
    Czyzyk DJ; Valhondo M; Jorgensen WL; Anderson KS
    FEBS Lett; 2019 Aug; 593(15):2069-2078. PubMed ID: 31172516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic characterization of bifunctional thymidylate synthase-dihydrofolate reductase (TS-DHFR) from Cryptosporidium hominis: a paradigm shift for ts activity and channeling behavior.
    Atreya CE; Anderson KS
    J Biol Chem; 2004 Apr; 279(18):18314-22. PubMed ID: 14966126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structures of dihydrofolate reductase-thymidylate synthase of Trypanosoma cruzi in the folate-free state and in complex with two antifolate drugs, trimetrexate and methotrexate.
    Senkovich O; Schormann N; Chattopadhyay D
    Acta Crystallogr D Biol Crystallogr; 2009 Jul; 65(Pt 7):704-16. PubMed ID: 19564691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential antifolate resistance determinants and genotypic variation in the bifunctional dihydrofolate reductase-thymidylate synthase gene from human and bovine isolates of Cryptosporidium parvum.
    Vásquez JR; Goozé L; Kim K; Gut J; Petersen C; Nelson RG
    Mol Biochem Parasitol; 1996 Aug; 79(2):153-65. PubMed ID: 8855552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substituted pyrrolo[2,3-d]pyrimidines as Cryptosporidium hominis thymidylate synthase inhibitors.
    Kumar VP; Frey KM; Wang Y; Jain HK; Gangjee A; Anderson KS
    Bioorg Med Chem Lett; 2013 Oct; 23(19):5426-8. PubMed ID: 23927969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying antimalarial compounds targeting dihydrofolate reductase-thymidylate synthase (DHFR-TS) by chemogenomic profiling.
    Aroonsri A; Akinola O; Posayapisit N; Songsungthong W; Uthaipibull C; Kamchonwongpaisan S; Gbotosho GO; Yuthavong Y; Shaw PJ
    Int J Parasitol; 2016 Jul; 46(8):527-35. PubMed ID: 27150044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly efficient ligands for dihydrofolate reductase from Cryptosporidium hominis and Toxoplasma gondii inspired by structural analysis.
    Pelphrey PM; Popov VM; Joska TM; Beierlein JM; Bolstad ES; Fillingham YA; Wright DL; Anderson AC
    J Med Chem; 2007 Mar; 50(5):940-50. PubMed ID: 17269758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nanotherapy strategy significantly enhances anticryptosporidial activity of an inhibitor of bifunctional thymidylate synthase-dihydrofolate reductase from Cryptosporidium.
    Mukerjee A; Iyidogan P; Castellanos-Gonzalez A; Cisneros JA; Czyzyk D; Ranjan AP; Jorgensen WL; White AC; Vishwanatha JK; Anderson KS
    Bioorg Med Chem Lett; 2015; 25(10):2065-7. PubMed ID: 25900220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent dual thymidylate synthase and dihydrofolate reductase inhibitors: classical and nonclassical 2-amino-4-oxo-5-arylthio-substituted-6-methylthieno[2,3-d]pyrimidine antifolates.
    Gangjee A; Qiu Y; Li W; Kisliuk RL
    J Med Chem; 2008 Sep; 51(18):5789-97. PubMed ID: 18800768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Cryptosporidium parvum dihydrofolate reductase inhibitors by complementation in Saccharomyces cerevisiae.
    Brophy VH; Vasquez J; Nelson RG; Forney JR; Rosowsky A; Sibley CH
    Antimicrob Agents Chemother; 2000 Apr; 44(4):1019-28. PubMed ID: 10722506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting DHFR in parasitic protozoa.
    Anderson AC
    Drug Discov Today; 2005 Jan; 10(2):121-8. PubMed ID: 15718161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploiting structural analysis, in silico screening, and serendipity to identify novel inhibitors of drug-resistant falciparum malaria.
    Dasgupta T; Chitnumsub P; Kamchonwongpaisan S; Maneeruttanarungroj C; Nichols SE; Lyons TM; Tirado-Rives J; Jorgensen WL; Yuthavong Y; Anderson KS
    ACS Chem Biol; 2009 Jan; 4(1):29-40. PubMed ID: 19146480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.